Bezos Joins Gates-Backed Alzheimer’s Diagnostics Accelerator With New Focus On Digital Biomarkers

Bill Gates and Amazon founder Jeff Bezos—the two richest men in the world—are joining to back efforts to innovate new ways to diagnose and track Alzheimer’s disease. The support of two will help push forward efforts by the “venture philanthropy” project of the Alzheimer’s Drug Discovery Foundation (ADDF).

In the near future, ADDF is expected to name its first grantees, and is currently in the process of receiving applications for a second round of grants it is awarding, which focus on fast-tracking digital tools for Alzheimer’s and related dementias. Having launched last July, the . . .